Author

J.-Q. Yuan

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

A novel metabolic imbalance index combining insulin resistance and inflammation for cardiovascular prognosis: evidence from three international cohorts in middle-aged and older adults

Chronic inflammation and insulin resistance are key pathophysiological mechanisms underlying cardiovascular disease (CVD). Persistent low-grade inflammation promotes endothelial dysfunction and accelerates atherosclerotic plaque formation. Insulin resistance contributes to metabolic disturbances, including hyperg...

M.-L. Liu, K. Yan, K.-X. Zhang et al. · European Heart Journal · 0 citations

Oct 2026

Assessment of individual and combined ACC scientific statement-recommended inflammatory markers for long-term prognostication in coronary heart disease: a two-cohort study

Chronic inflammation and coronary artery disease(CAD) have been research hotspots in recent years. In 2025, the American College of Cardiology (ACC) issued a Scientific Statement highlighting a broader panel of inflammatory markers for risk refinement, including clinically accessible indicators, including the est...

F. Xu, K. Yan, K.-X. Zhang et al. · European Heart Journal · 0 citations

Open access Oct 2026

Association of the Chinese visceral adiposity index with incident cardio-renal-metabolic multimorbidity: a 9-year nationwide cohort study

The Chinese Visceral Adiposity Index (CVAI) is an improved surrogate marker of visceral adiposity, yet prospective evidence linking CVAI to cardio-renal-metabolic multimorbidity (CRMM) is limited. To evaluate the predictive performance of CVAI for CRMM and its association with incident CRMM risk. A...

Y. Song, Q. Sun, J. Zhang et al. · European Heart Journal · 0 citations

Open access Oct 2026

Combining polygenic risk score and high platelet reactivity for incremental predictive value of acute myocardial infarction in patients with coronary artery disease with 10-year follow-up

Genetic risk affect prognosis of coronary heart disease. High platelet reactivity(HPR) under antiplatelet treatment is associated with increased risks of adverse cardiovascular events. Our study aims to explore whether combining polygenic risk and HPR can provide incremental predictive value for acute myoc...

Y. Yao, N. Xu, X.-F. Lu et al. · European Heart Journal · 0 citations

Oct 2026

[Dual association of peripheral blood eosinophil count with high on-treatment platelet reactivity and long-term cardiac death in patients with coronary artery disease: a large-scale cohort study].

In patients with coronary artery disease undergoing PCI and receiving clopidogrel, baseline peripheral blood eosinophil count showed a dual association with high on-treatment platelet reactivity and long-term cardiac death.

Z.-H. Ke, K. Yan, D. Yuan et al. · Zhonghua xin xue guan bing z... · 0 citations